The Challenge of Drug Development

A significant challenge in the pharmaceutical industry is the high failure rate of drug candidates in clinical trials, with 90% ultimately failing to reach patients. This reflects the immense complexity of biological systems and the limitations of traditional approaches to drug discovery. Many researchers typically focus on one disease at a time without integrating broader biological data. By leveraging advanced technologies such as AI and automation, Recursion aims to create comprehensive maps of biological interactions and enhance the drug development process, shifting from conventional methods to a more industrialized approach.